In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone.

In vitro activity of LB20304 against 1,231 clinical isolates was evaluated and compared with those of ciprofloxacin, sparfloxacin, lomefloxacin, and ofloxacin. LB20304 demonstrated the most potent activity against gram-positive bacteria. It was 32- to 64-fold more active than ciprofloxacin against m...

Volledige beschrijving

Bibliografische gegevens

Gepubliceerd in:	Antimicrob Agents Chemother
Hoofdauteurs:	Oh, J I, Paek, K S, Ahn, M J, Kim, M Y, Hong, C Y, Kim, I C, Kwak, J H
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	American Society for Microbiology (ASM) 1996
Onderwerpen:	Research Article
Online toegang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163372/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8726042/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.6.1564
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!